Results 251 to 260 of about 180,947 (337)
Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study [PDF]
David Laharie +8 more
openalex +1 more source
Patterns of parenteral nutrition use in the inpatient setting: A retrospective cohort study
Abstract Background Parenteral nutrition (PN) supports patients unable to absorb sufficient nutrients from their gastrointestinal tracts. Yet, information about the patterns and extent of PN's in‐hospital use is lacking. Data on this topic should provide comparison points for nutrition support teams and hospital administrators examining PN use in their
Marc Romain +7 more
wiley +1 more source
Adolescent Crohn's disease: A nursing case report. [PDF]
Wang X, Zhang N, Ma H.
europepmc +1 more source
Self-reported sleep disturbance in Crohn’s disease is not confrmed by objective sleep measures [PDF]
Ciorba, Matthew A. +7 more
core +1 more source
Advancing Extracellular Vesicle Research: A Review of Systems Biology and Multiomics Perspectives
ABSTRACT Extracellular vesicles (EVs) are membrane‐bound vesicles secreted by various cell types into the extracellular space and play a role in intercellular communication. Their molecular cargo varies depending on the cell of origin and its functional state.
Gloria Kemunto +2 more
wiley +1 more source
Can Creeping Fat Be a Prognostic Factor in Crohn's Disease? [PDF]
Demiral N +6 more
europepmc +1 more source
Abstract Mirikizumab is a p19‐directed anti‐interleukin‐23 antibody approved for the treatment of adults with moderate‐to‐severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure–response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate‐to‐severe UC
Yuki Otani +5 more
wiley +1 more source
Small Bowel Adenocarcinoma Masquerading as Crohn's Disease. [PDF]
Kim SY, Wiggins B, Ramirez D, Minaudo M.
europepmc +1 more source

